Both in Pharmaceuticals
Rocket Pharmaceuticals vs ARS Pharmaceuticals
Over the past year RCKT returned −20.7% and SPRY returned −65.0%; their daily moves had a correlation of 0.31.
RCKT −20.7% SPRY −65.0%Growth of $1, one year, split-adjusted
| Metric | RCKT | SPRY |
|---|---|---|
| Price | $2.61 | $3.05 |
| Market cap | $286.5M | $303.3M |
| Today | +3.98% | 0.00% |
| 1 month | +5.2% | −29.0% |
| 6 months | −32.4% | −67.1% |
| Year to date | −25.6% | −73.8% |
| 1 year | −26.7% | −64.6% |
| Revenue growth (YoY) | — | +114.2% |
| Gross margin | — | 61.8% |
| Net margin | — | −185.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.6× |
| Net cash | $262.5M | -$27.8M |
| Dividend yield | — | — |
| Volatility (60d) | 66.6% | 69.9% |
| Short % of float | 19.2% | 40.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).